State Key Laboratory of Silkworm Genome Biology, College of Pharmaceutical Sciences, Southwest University, Chongqing 400700, China.
Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
Adv Drug Deliv Rev. 2023 Jul;198:114874. doi: 10.1016/j.addr.2023.114874. Epub 2023 May 19.
The growing occurrence of invasive fungal infections and the mounting rates of drug resistance constitute a significant menace to human health. Antifungal drug combinations have garnered substantial interest for their potential to improve therapeutic efficacy, reduce drug doses, reverse, or ameliorate drug resistance. A thorough understanding of the molecular mechanisms underlying antifungal drug resistance and drug combination is key to developing new drug combinations. Here we discuss the mechanisms of antifungal drug resistance and elucidate how to discover potent drug combinations to surmount resistance. We also examine the challenges encountered in developing such combinations and discuss prospects, including advanced drug delivery strategies.
侵袭性真菌感染的发生率不断增加,耐药率不断上升,这对人类健康构成了重大威胁。抗真菌药物联合应用因其潜在的提高治疗效果、减少药物剂量、逆转或改善耐药性而引起了广泛关注。深入了解抗真菌药物耐药性和药物联合作用的分子机制是开发新的药物联合应用的关键。在这里,我们讨论了抗真菌药物耐药性的机制,并阐明了如何发现有效的药物联合应用来克服耐药性。我们还研究了开发这些联合应用所面临的挑战,并讨论了包括先进的药物输送策略在内的前景。